ERIS Q1 FY27 results at a glance
ERIS LIFESCIENCES LIMITED Q1 FY27 key results metrics| Quarter | Q1 FY27 |
|---|
| Quarter ended | 30 Jun 2026 |
|---|
| Revenue | ₹869 cr |
|---|
| Revenue YoY | +12.6% |
|---|
| Operating profit | ₹224 cr |
|---|
| Operating margin | 25.8% |
|---|
| Net profit | ₹142 cr |
|---|
| Net profit YoY | +20.7% |
|---|
| Net profit QoQ | -49.4% |
|---|
| Net margin | 16.4% |
|---|
| Basic EPS | ₹10.28 |
|---|
| TTM revenue | ₹3,212 cr |
|---|
| TTM net profit | ₹644 cr |
|---|
| TTM net margin | 20.0% |
|---|
ERIS Q1 FY27 results: what the numbers say
ERIS LIFESCIENCES LIMITED (ERIS) has reported its Q1 FY27 results for the quarter ended 2026-06-30. The company posted revenue of ₹869 cr and a net profit of ₹142 cr, translating into earnings per share of ₹10.28.
Compared with the same quarter a year earlier, revenue grew by +12.6% and net profit grew strongly by +20.7%. Profit rising faster than revenue points to better cost control or operating leverage flowing through the P&L.
Operating profit for the quarter stood at ₹224 cr, an operating margin of 25.8% versus 26.7% a year ago — a contraction of 0.9 percentage points.
ERIS quarter-wise results table
Net profit
₹142 cr
+20.7% YoY
Operating profit
₹224 cr
+8.7% YoY
ERIS LIFESCIENCES LIMITED (ERIS) quarter-wise results — revenue, operating profit, net profit, margins, EPS and growth| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|
| Q1 FY272026-06-30 | ₹869 cr | ₹224 cr | ₹142 cr | 25.8% | 16.4% | ₹10.28 | +20.7% | -49.4% |
| Q4 FY262026-03-31 | ₹752 cr | ₹204 cr | ₹282 cr | 27.1% | 37.4% | ₹20.60 | — | +182.4% |
| Q3 FY262025-12-31 | ₹801 cr | ₹211 cr | ₹99.72 cr | 26.4% | 12.5% | ₹7.32 | — | -17.0% |
| Q2 FY262025-09-30 | ₹790 cr | ₹219 cr | ₹120 cr | 27.7% | 15.2% | ₹8.82 | — | +1.9% |
| Q1 FY262025-06-30 | ₹772 cr | ₹206 cr | ₹118 cr | 26.7% | 15.3% | ₹8.66 | — | — |
| TTM (last 4 quarters) | ₹3,212 cr | ₹859 cr | ₹644 cr | 26.7% | 20.0% | ₹47.02 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
ERIS quarterly income statement
Line-item results for the last six quarters as filed — sales, expenses, operating profit, interest, tax and profit after tax in ₹ crore.
ERIS LIFESCIENCES LIMITED quarterly income statement| Particulars | Q1 FY272026-06-30 | Q4 FY262026-03-31 | Q3 FY262025-12-31 | Q2 FY262025-09-30 | Q1 FY262025-06-30 |
|---|
| Revenue / Sales | ₹869 cr | ₹752 cr | ₹801 cr | ₹790 cr | ₹772 cr |
|---|
| Total expenses | ₹645 cr | ₹548 cr | ₹590 cr | ₹571 cr | ₹565 cr |
|---|
| Gross profit | ₹630 cr | ₹567 cr | ₹578 cr | ₹588 cr | ₹587 cr |
|---|
| Operating profit (EBIT) | ₹224 cr | ₹204 cr | ₹211 cr | ₹219 cr | ₹206 cr |
|---|
| Operating margin | 25.8% | 27.1% | 26.4% | 27.7% | 26.7% |
|---|
| Interest cost | ₹46.65 cr | ₹45.62 cr | ₹48.82 cr | ₹49.55 cr | ₹48.68 cr |
|---|
| Profit before tax | ₹179 cr | ₹159 cr | ₹145 cr | ₹173 cr | ₹161 cr |
|---|
| Tax expense | ₹36.17 cr | -₹120 cr | ₹36.52 cr | ₹38.2 cr | ₹36 cr |
|---|
| Effective tax rate | 20.2% | -75.1% | 25.1% | 22.1% | 22.3% |
|---|
| Net profit (PAT) | ₹142 cr | ₹282 cr | ₹99.72 cr | ₹120 cr | ₹118 cr |
|---|
| Net profit margin | 16.4% | 37.4% | 12.5% | 15.2% | 15.3% |
|---|
| Basic EPS | ₹10.28 | ₹20.60 | ₹7.32 | ₹8.82 | ₹8.66 |
|---|
| Diluted EPS | ₹10.26 | ₹20.57 | ₹7.32 | ₹8.81 | ₹8.64 |
|---|
ERIS results growth — YoY and QoQ
Quarterly growth rates, year on year and quarter on quarter| Growth | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|
| Revenue YoY | +12.6% | — | — | — | — |
|---|
| Revenue QoQ | +15.5% | -6.1% | +1.4% | +2.4% | — |
|---|
| Operating profit YoY | +8.7% | — | — | — | — |
|---|
| Operating profit QoQ | +9.8% | -3.4% | -3.6% | +6.3% | — |
|---|
| Net profit YoY | +20.7% | — | — | — | — |
|---|
| Net profit QoQ | -49.4% | +182.4% | -17.0% | +1.9% | — |
|---|
| EPS YoY | +18.7% | — | — | — | — |
|---|
| EPS QoQ | -50.1% | +181.4% | -17.0% | +1.8% | — |
|---|
ERIS annual results history
Full-year performance for ERIS LIFESCIENCES LIMITED, useful for reading each quarter in context.
ERIS LIFESCIENCES LIMITED annual income statement| Particulars | FY262026-03-31 | FY252025-03-31 | FY242024-03-31 | FY232023-03-31 |
|---|
| Revenue / Sales | ₹3,115 cr | ₹2,879 cr | ₹1,991 cr | ₹1,662 cr |
|---|
| Total expenses | ₹2,274 cr | ₹2,176 cr | ₹1,496 cr | ₹1,240 cr |
|---|
| Gross profit | ₹2,297 cr | ₹2,149 cr | ₹1,604 cr | ₹1,305 cr |
|---|
| Operating profit (EBIT) | ₹841 cr | ₹703 cr | ₹495 cr | ₹422 cr |
|---|
| Operating margin | 27.0% | 24.4% | 24.9% | 25.4% |
|---|
| Interest cost | ₹193 cr | ₹231 cr | ₹84.8 cr | ₹26.17 cr |
|---|
| Profit before tax | ₹639 cr | ₹489 cr | ₹431 cr | ₹405 cr |
|---|
| Tax expense | -₹8.97 cr | ₹114 cr | ₹34.22 cr | ₹30.48 cr |
|---|
| Effective tax rate | -1.4% | 23.4% | 7.9% | 7.5% |
|---|
| Net profit (PAT) | ₹620 cr | ₹352 cr | ₹392 cr | ₹382 cr |
|---|
| Net profit margin | 19.9% | 12.2% | 19.7% | 23.0% |
|---|
| Basic EPS | ₹45.33 | ₹25.85 | ₹28.82 | ₹28.10 |
|---|
| Diluted EPS | ₹45.26 | ₹25.81 | ₹28.79 | ₹28.07 |
|---|
Revenue trend and demand read-through
Topline for Q1 FY27 came in at ₹869 cr against ₹772 cr in Q1 FY26, and ₹752 cr in the preceding Q4 FY26 quarter.
On a sequential basis revenue grew +15.5%. Sequential moves are the quickest read on demand momentum because they strip out the base effect of a year-old quarter, though seasonality can distort a single quarter.
Total expenses for the quarter were ₹645 cr, or 74.2% of revenue, with operating profit grew +8.7% year on year.
Margins, tax and profitability
Net profit of ₹142 cr works out to a net margin of 16.4% compared with 15.3% in the year-ago quarter. Margin expansion of this kind usually reflects a better product or service mix, softer input costs, or tighter overheads.
Below the operating line, ERIS LIFESCIENCES LIMITED reported profit before tax of ₹179 cr, a tax charge of ₹36.17 cr (effective rate 20.2%), interest cost of ₹46.65 cr. Reading these together with operating profit shows how much of the quarter's earnings were driven by the core business versus financing and tax movements.
Sequentially, net profit moved from ₹282 cr in Q4 FY26 to ₹142 cr in Q1 FY27, a change of -49.4%.
Trailing twelve months and annual context
Across the trailing four quarters ERIS LIFESCIENCES LIMITED has generated revenue of ₹3,212 cr and net profit of ₹644 cr, a trailing net margin of 20.0%. The trailing view smooths out one-off quarters and is the number most valuation multiples are built on.
On a full-year basis, FY26 revenue was ₹3,115 cr with net profit of ₹620 cr and EPS of ₹45.33, versus the prior year where revenue grew +8.2% and profit grew +76.1%.
What to watch in the next ERIS quarter
For the coming quarters the numbers worth tracking on this page are revenue momentum, the operating margin trend, the interest burden and whether EPS keeps pace with profit growth. A sustained run of year-on-year profit growth is what usually drives a re-rating rather than any single quarter.
ERIS LIFESCIENCES LIMITED has not yet intimated its next results date to the exchange. This page refreshes automatically from filings and the board-meeting calendar, so the tables above will reflect the next quarter as soon as it is reported.
All figures here are as reported to the exchanges and shown in ₹ crore, without adjustment. This is information and analysis, not investment advice.
ERIS results coverage
No results report published for ERIS yet — our desk covers each quarter within minutes of the filing.
ERIS quarterly results FAQs
What were ERIS LIFESCIENCES LIMITED (ERIS) Q1 FY27 results?
In Q1 FY27 (quarter ended 30 Jun 2026), ERIS LIFESCIENCES LIMITED reported revenue of ₹869 cr and net profit of ₹142 cr, a change of +20.7% year on year on +12.6% revenue growth. EPS stood at ₹10.28.
What is ERIS profit margin in Q1 FY27?
ERIS LIFESCIENCES LIMITED posted a net profit margin of 16.4% and an operating margin of 25.8% in Q1 FY27. On a trailing twelve-month basis, revenue is ₹3,212 cr and net profit ₹644 cr.
Did ERIS results beat the previous quarter?
ERIS LIFESCIENCES LIMITED net profit changed -49.4% quarter on quarter, from ₹282 cr in Q4 FY26 to ₹142 cr in Q1 FY27.
When are ERIS LIFESCIENCES LIMITED (ERIS) quarterly results?
ERIS LIFESCIENCES LIMITED has not yet intimated its next results date to the exchange. This page updates automatically from the exchange board-meeting calendar.
Where can I see ERIS latest quarterly results?
Results coverage for ERIS will appear here as soon as the company reports. Meanwhile you can track live price and technicals on the ERIS stock page.
What is ERIS LIFESCIENCES LIMITED annual revenue and profit?
For FY26, ERIS LIFESCIENCES LIMITED reported full-year revenue of ₹3,115 cr and net profit of ₹620 cr, with EPS of ₹45.33.
How many quarterly results has ERIS declared recently?
Past results dates for ERIS will be listed here from the exchange calendar.
Results dates sourced from the exchange board-meeting calendar; reported figures from company filings, last refreshed 12 Sept 2026. For information only, not investment advice.
